Monoclonal nature of transient abnormal myelopoiesis in Down's syndrome. 1991

H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
Department of Pediatrics, Osaka University Hospital, Japan.

Neonates with Down's syndrome occasionally show an excess of blasts in their peripheral blood. This disorder spontaneously resolves within several months and is called transient abnormal myelopoiesis (TAM) or transient myeloproliferative disorder. It has been uncertain whether the excess of blasts in TAM is a result of a clonal proliferation or a polyclonal reactive condition. The clonality of cells in females can be examined by analysis of the methylation patterns of the X chromosomes of proliferating cells using restriction fragment length polymorphism (RFLP). Using this strategy, we studied three females with Down's syndrome accompanied by TAM who showed heterozygosity in RFLP of either the hypoxanthine phosphoribosyltransferase or phosphoglycerate kinase gene. Analysis of the methylation patterns of these genes demonstrated a clonal nature for blasts in three patients. Thus, TAM is a clonal proliferative disorder. In addition, lymphocytes with a normal appearance contained in analyzed samples from these patients also showed a monoclonal pattern, suggesting that TAM may be a disorder of multipotent stem cells.

UI MeSH Term Description Entries
D007041 Hypoxanthine Phosphoribosyltransferase An enzyme that catalyzes the conversion of 5-phosphoribosyl-1-pyrophosphate and hypoxanthine, guanine, or MERCAPTOPURINE to the corresponding 5'-mononucleotides and pyrophosphate. The enzyme is important in purine biosynthesis as well as central nervous system functions. Complete lack of enzyme activity is associated with the LESCH-NYHAN SYNDROME, while partial deficiency results in overproduction of uric acid. EC 2.4.2.8. Guanine Phosphoribosyltransferase,HPRT,Hypoxanthine-Guanine Phosphoribosyltransferase,IMP Pyrophosphorylase,HGPRT,HPRTase,Hypoxanthine Guanine Phosphoribosyltransferase,Phosphoribosyltransferase, Guanine,Phosphoribosyltransferase, Hypoxanthine,Phosphoribosyltransferase, Hypoxanthine-Guanine,Pyrophosphorylase, IMP
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008297 Male Males
D008745 Methylation Addition of methyl groups. In histo-chemistry methylation is used to esterify carboxyl groups and remove sulfate groups by treating tissue sections with hot methanol in the presence of hydrochloric acid. (From Stedman, 25th ed) Methylations
D009196 Myeloproliferative Disorders Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE. Disorder, Myeloproliferative,Disorders, Myeloproliferative,Myeloproliferative Disorder
D010735 Phosphoglycerate Kinase An enzyme catalyzing the transfer of a phosphate group from 3-phospho-D-glycerate in the presence of ATP to yield 3-phospho-D-glyceroyl phosphate and ADP. EC 2.7.2.3. Kinase, Phosphoglycerate
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell

Related Publications

H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
November 1994, The American journal of pediatric hematology/oncology,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
January 1991, Leukemia & lymphoma,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
August 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
January 1997, Acta haematologica,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
January 1992, Leukemia research,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
March 2001, British journal of haematology,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
August 2000, The journal of obstetrics and gynaecology research,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
December 2002, Journal of pediatric hematology/oncology,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
February 2001, Pediatrics international : official journal of the Japan Pediatric Society,
H Kurahashi, and J Hara, and K Yumura-Yagi, and N Murayama, and M Inoue, and S Ishihara, and A Tawa, and S Okada, and K Kawa-Ha
February 1990, Acta paediatrica Scandinavica,
Copied contents to your clipboard!